Safety of Batracylin in Patients With Solid Tumors and Lymphomas
|ClinicalTrials.gov Identifier: NCT00450502|
Recruitment Status : Completed
First Posted : March 22, 2007
Last Update Posted : March 8, 2018
National Cancer Institute (NCI)
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||April 24, 2011|
|Actual Study Completion Date :||April 24, 2011|
Ames MM, Mathiesen DA, Reid JM. Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the rat. Invest New Drugs. 1991 Aug;9(3):219-25.
Stevens GJ, Burkey JL, McQueen CA. Toxicity of the heterocyclic amine batracylin: investigation of rodent N-acetyltransferase activity and potential contribution of cytochrome P450 3A. Cell Biol Toxicol. 2000;16(1):31-9.